Health Highlights: May 15, 2005
Retailers to Tighten Sales of Cold Meds Chiropractor in Botox Probe Gets License Back States Warn Cigarette Maker on Ad Claims U.S. Might Consider Flu Shots for All Sealants Reduce Cancer Risk From Arsenic-Treated Wood: EPA
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Retailers to Tighten Sales of Cold Meds
Several major retailers will move many over-the-counter cold medications from store shelves to pharmacy shelves in the next two months, as they work with law enforcement officials to curb the use of an illegal drug, the Washington Post reports.
In some cases, customers will have to show their driver's licenses and sign a log to buy medicines that contain pseudophedrine, a common decongestant, the Post reported. The stores involved include Target, Wal-Mart, Rite-Aid and others.
"It will be a big change for consumers," Jody Cook, a spokeswoman for Rite Aid Corp., told the Post. The move will affect more than 100 products, including common brands such as Sudafed, Tylenol Cold and Claritin-D.
Pseudophedrine is needed to make the dangerous and addictive drug methamphetamine. Criminals are stealing over-the-counter medicines, or buying as much as they can, and using them to make the illicit drug, the Post reported.
"This problem is so severe in many parts of the country that our retailers are making sacrifices to help law enforcement in their efforts," Mary Ann Wagner, vice president of pharmacy regulatory affairs for the National Association of Chain Drug Stores, told the Post.
Meth production and abuse has been a big problem in the Midwest and the West, where some states and counties have enacted or are considering regulations that restrict the sale of over-the-counter cold medications.
Chiropractor in Botox Probe Gets License Back
The Florida Board of Chiropractic Medicine has ruled that the chiropractor who owned the clinic where four people were paralyzed by injections of raw botulism last November can start seeing patients again, the Associated Press reported Sunday.
Thomas Toia had been placed on supervised probation for three years and ordered to pay a $10,000 fine, but the latest ruling, which came Friday, allows him to regain his suspended license, the AP reported. Bach McComb, a doctor at Toia's clinic, injected himself, his girlfriend and two friends with powerful, unapproved research toxin, which was cheaper than federally approved Botox. All four were paralyzed for months.
The board found Toia hired questionable doctors, didn't monitor them and did little when the four people got sick in November. Toia told the board he didn't know the raw toxin had been ordered and administered, and he told the group to go to the emergency room when he learned of their condition, the AP reported.
States Warn Cigarette Maker on Ad Claims
A group representing 40 state attorneys general is warning R.J. Reynolds Tobacco Co. that the company may face state lawsuits over claims that Eclipse cigarettes may lessen the risks of certain smoking-related diseases.
Reynolds disclosed the letter from the National Association of Attorneys General this week in a filing with the U.S. Securities and Exchange Commission, the Associated Press reported.
The letter accuses the firm of engaging in "unfair and deceptive acts and practices by publishing false or misleading claims" about the cigarettes, the wire service said.
Reynolds said it has evidence to support its claims that the cigarettes, which mostly heat tobacco instead of burning it, reduce secondhand smoke by up to 80 percent. The company claims the cigarettes also leave no lingering odor, the AP said.
The attorneys general, who said they have a meeting with company representatives planned for next week, said they believe Reynolds has violated a $206 billion landmark agreement reached in 1998 between the states and the nation's cigarette makers.
As with similar brands that claim to reduce the harmful effects of smoking, the Eclipse brand has never caught on with most smokers, the AP said.
U.S. Might Consider Flu Shots for All
Within five years, the U.S. government could recommend yearly flu shots for every American as a way to help stem future epidemics, the Associated Press reported.
The idea was discussed this week at a meeting of flu experts in Chicago. The proposal was floated amid concern that there may not even be enough vaccine for the upcoming season to inoculate those at greatest risk -- including the elderly, the very young, and people with compromised immune systems.
So far, only one company, Sanofi Pasteur, is licensed to produce the flu vaccine in the United States. A second company, Chiron Corp., recently began production again after the British government last fall abruptly closed the company's Liverpool, England, plant due to contamination problems. The move sparked widespread vaccine shortages in the United States for several months. Chiron hasn't yet been approved by the U.S. government to sell the vaccine again in the United States.
Flu vaccine is normally changed every year to reflect what experts expect will be the dominant strains. The fact that extra supply is usually discarded after the season makes production unappealing to many manufacturers, the AP said.
In an average year, flu sickens 82 million people in the United States, killing about 36,000, the wire service reported.
Sealants Reduce Cancer Risk From Arsenic-Treated Wood: EPA
Using oil- or water-based sealants or stains once a year can reduce the cancer risk from arsenic-treated wood by limiting the amount of arsenic that can escape and come into contact with people's skin, says the U.S. Environmental Protection Agency.
Arsenic-treated wood is commonly found in children's playground equipment and backyard decks.
Results from the first year of a two-year study by the EPA and the Consumer Product Safety Commission found that sealants and stains successfully contained the release of arsenic from wood treated with the pesticide chromated copper arsenate (CCA), the Associated Press reported.
The sealants and stains are better than paints or other products that can chip or flake and require scraping or sanding for removal, which can increase exposure to arsenic, the EPA said.
Exposure to CCA results in a marginally increased risk of cancer in children age 1 to 6, according to preliminary EPA studies. The EPA has removed CCA from its list of approved chemicals and the lumber industry has stopped making new products with CAA, the AP reported.